Abbott Receives CE Mark for Next-Generation Amulet 360 Device for Stroke Prevention in AFib
Abbott’s Amulet 360 LAA Occluder has received CE Mark approval in Europe, expanding options for minimally invasive stroke prevention among patients with non-valvular atrial fibrillation.
Non-valvular Atrial Fibrillation | 31/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy